Source | fhir.dicom#2023.1.20230123:null (v4.0.1) |
resourceType | ValueSet |
id | dicom-cid-10043-IntravenousExtravasationSymptom |
canonical | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10043.html |
version | 2023.1.20230123 |
status | active |
publisher | NEMA MITA DICOM |
name | IntravenousExtravasationSymptom |
date | 2023-01-23 |
experimental | false |
description | Transitive closure of CID 10043 IntravenousExtravasationSymptom |
copyright | © 2023 NEMA |
Usages | (none) |
This value set includes codes based on the following rules:
http://dicom.nema.org/resources/ontology/DCM
Code | Display | Definition |
113568 | Extravasation visible in image | Extravasation or paravenous administration of the product is visible in the images. |
http://snomed.info/sct
Code | Display |
95401009 | Injection site bruising |
95386001 | Injection site thrombosis |
95382004 | Injection site abscess |
95390004 | Injection site nerve damage |
95403007 | Injection site fibrosis |
95378001 | Injection site hypersensitivity |
95380007 | Injection site pigmentation change |
111017005 | Injection site scar |
95379009 | Injection site irritation |
95398006 | Injection site anesthesia |
95396005 | Injection site cyst |
95402002 | Injection site induration |
95392007 | Injection site edema |
95394008 | Injection site urticaria |
95404001 | Injection site atrophy |
95389008 | Injection site burning |
95385002 | Injection site hemorrhage |
95400005 | Injection site ulcer |
95387005 | Injection site malabsorption |
95383009 | Injection site sterile abscess |
95391000 | Injection site inflammation |
95381006 | Injection site infection |
95397001 | Injection site necrosis |
95399003 | Injection site paresthesia |
95393002 | Injection site dermatitis |
95376002 | Injection site disorder |
95388000 | Injection site pain |
95395009 | Injection site mass |
24389009 | Injection site granuloma |
Produced 06 Apr 2023